News for Predictive Oncology Inc. (POAI)

Key Takeaways: Predictive Oncology's major shareholders are selling 1.92 million shares, potentially impacting market dynamics. Analysts project signific

Predictive Oncology, under the ticker POAI, has declared its intention to sell 1.92 million shares of common stock. This move involves offering shares held by c

Predictive Oncology (POAI) recently provided a shareholder update highlighting significant advancements within the company. A key focus has been on their innova

Predictive Oncology (POAI) has responded to a legal clash with Renovaro (RENB), clarifying recent developments in the dispute. The Delaware Court of Chancery ha

PITTSBURGH, May 27, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. ( POAI), a leader in AI-driven drug discovery, today issued the following statement rega

Renovaro Inc. (NASDAQ:RENB) stated that the Delaware Court of Chancery has granted an expedited trial to its action against Predictive Oncology Inc. (NASDAQ:POAI), which was filed on May 9, 2025. A binding merger agreement signed on January 1, 2025, which called for Predictive Oncology to merge into Renovaro Inc. (NASDAQ:RENB) in exchange for a new […]

Renovaro has been granted a fast-tracked trial set for 2025 in its lawsuit against Predictive Oncology (POAI), originally filed on May 9 in the Delaware Court o

Renovaro Inc. (RENB) secures expedited trial for a 2025 lawsuit against Predictive Oncology (POAI). The lawsuit seeks to enforce a binding merger agreem

**media[634486]**

Company Leverages More Than Twenty Years of Drug Response Data Derived from Massive Biobank of Live Cell Tumor Samples PITTSBURGH, May 22, 2025 (GLOBE NEWSW

Predictive Oncology (POAI) is utilizing its extensive biobank of over 150,000 diverse live cell tumor samples along with drug response data to enhance drug disc

**media[631622]**

PITTSBURGH, May 15, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology ( POAI), a science-driven company leveraging its proprietary artificial intelligence and mach

Predictive Oncology (POAI) reported a striking increase in its first-quarter revenue for 2025, reaching $110,310 compared to just $4,858 in the same period last

PALM BEACH, Fla., May 12, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Artificial Intelligence (AI) is becoming more essential in the medical mar

PALM BEACH, Fla., April 29, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to reports from industry insiders the Global AI in Diabetic Re

LOS ANGELES, April 04, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. ( RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, an

Renovaro BioSciences disputes Predictive Oncology's merger termination, citing binding obligations.

**media[586156]**